by Jill Svete | Dec 22, 2023 | Newsletters
By Bill Frack, Chief Product Officer Are you overpaying your point solution vendor? Employers are increasingly turning to specialized vendors (“point solutions”) to enhance their health plans – to better manage chronic conditions, facilitate access to higher quality...
by Jill Svete | Nov 2, 2023 | Newsletters
By Bill Frack, Chief Product Officer It’s open enrollment season. Maybe you’re wondering: Should my health plan members 65 or older enroll in Medicare? In most cases, the answer is YES, it’s in their best interest! How do you know whether Medicare is better for my...
by Jill Svete | Sep 13, 2023 | Newsletters
By Bill Frack, Chief Product Officer Another benefit renewal season is almost complete, and many employers have been told that – barring action – their second largest fixed expense will be increasing by 7%+. The actuaries are expecting inflation to flow through...
by Jill Svete | Aug 17, 2023 | Newsletters
By Bill Frack, Chief Product Officer Situation The journey to treat cancer is arduous, complicated, and expensive. Cancer care is the highest spend category for high-cost claimants in many employers’ health plans. Effective cancer care is a function of three key...
by boomer | Aug 2, 2023 | Newsletters
Situation The journey to treat cancer is arduous, complicated and expensive. Cancer care is the highest spend category for high-cost claimants in many employers’ health plans. Effective cancer care is a function of three key variables: Timely discovery – early stage...
by boomer | Jun 15, 2023 | Newsletters
By Jake Steepleton, Rx Product Specialist Situation Spending on GLP-1 drugs which treat Type 2 diabetes and obesity has surged. Weekly prescriptions for OZEMPIC® soared 111% between Feb 2022 to Feb 2023, making it the costliest drug for many employers, surpassing...
